Vitamin C in Atrial Fibrillation Ablation — VitC-AF

Atrial Fibrillation Ablation Clinical Trial

Official title:
Pilot Study of the Safety and Efficacy of Intravenous Vitamin C in Patients Undergoing Atrial Fibrillation Ablation

Status Completed

Clinical Trial Summary

Single-center, double-blinded, randomized, controlled safety and feasibility pilot study of high dose IV ascorbic acid (200mg/kg) over 24 hours, divided into four doses and administered every six hours with a 30 minute IV infusion time per dose, compared to matched placebo infusion

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03148236
Study type	Interventional
Source	Virginia Commonwealth University
Contact
Status	Completed
Phase	Phase 2
Start date	September 18, 2017
Completion date	March 13, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01034852` - Efficacy Study for Surgery After Previous Failed Catheter Ablation	N/A
Recruiting	`NCT06291506` - SUbstrate Ablation in Persistent Atrial Fibrillation for Elimination of Recurrences (SUPAFER).	N/A
Completed	`NCT05086861` - Oesophageal Pacing to Check Left Atrial Posterior Wall Isolation	N/A
Recruiting	`NCT00773539` - A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy	Phase 4
Completed	`NCT01730924` - Comparison of Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force Data	N/A